Home › Studies › PRJNA1004651
PRJNA1004651 SRP455548

Gut metagenome in ulcerative colitis patients, Chicago

Human gut metagenome, whole genomic shotgun sequencing

108 human gut metagenome samples from adults with ulcerative colitis in Chicago, Illinois, USA, collected as part of a longitudinal study of IBD-pouchitis susceptibility. machine-written summary

108 samples · 108 runs · US · Adult · 2023 · 10.04 Gbp / sample

Sources
✓Sequence archive 648✓Abstract / description 216–Full text–Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive648 sample values (country, latitude, location locality, location region, longitude, subject id)
✓ Abstract / description216 sample values (health condition, health condition detail)
– Full textno open-access full text linked · PMC13631169
– Supplementary tablesno supplementary tables available (or none open access)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention — arms not resolved

design observational_with_procedure

Samples at a glance
1 sampling locations · 1 country
Age
adult108
Condition
ulcerative_colitis108
Country
US108
Body site
primary108
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)this project, 0–0.03 Gbp: 3 samplesall projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 3 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 4 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 44 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 53 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)this project, 30–100 Gbp: 1 samplesall projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 10.04 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal — not resolved

9 of 10 people sampled more than once (107 samples; median 12, up to 23 per person). Schedule stated by the source: “month: 0, 4, 8, 12, 16, >16” (time origin: surgery).

How longitudinal and relatedness information is derived

Community composition
Bacteroides 8.8%Phocaeicola 8.8%Haemophilus_D 8.6%Escherichia 8.5%Prevotella 8.2%Mediterraneibacter 5.5%Clostridium 3.7%Roseburia 3.7%Veillonella 2.9%Cetobacterium_A 2.1%Faecalibacterium 1.8%Klebsiella 1.7%not assigned to a genus 14.1%other genera 21.5%

Genera, mean relative abundance over 84 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category108 100%
country108 100%108
health_condition108 100%108
subject_id108 100%108
detailed_location108 100%
health_condition_detail108 100%108
latitude108 100%108
location_locality108 100%108
location_region108 100%108
longitude108 100%108
Papers (1)
  • Metagenomics comparison identifies shared pathogenic microbiome in humans, pigs and chickens. 2026 PMID 42417977 PMC13631169 cites_accession
Details
Archive description

Host and microbial basis of human ulcerative colitis and pouchitis: Identification, role, mechanisms, and resource development of host susceptibility and pathobiont factors. PI Eugene B. Chang, University of Chicago. Inflammatory bowel diseases (IBD) result from the convergence of host, environmental, and microbial factors, each necessary, but not sufficient to cause disease. Yet, significant gaps in knowledge remain - among them, what underlies disease susceptibility and precipitates the onset of IBD. The need to better understand the causes that lead to these diseases remains a challenge. Post disease onset, numerous confounders and complications make it problematic to unravel the myriad of contributing factors. Not surprisingly, most human subject studies fail to go beyond description and association. Inability to sort out cause-effect relationship on a temporal basis further hinders efforts to improve clinical management and outcomes and to develop effective strategies for risk stratification and disease prevention. To address this issue, we propose a multi-disciplinary team approach that will use the lens of a unique clinical model to gain transformative insights that will help move the needle in IBD. The model involves a subset of patients with medically-refractory ulcerative colitis (UC) who have undergone total proctocolectomy with ileal pouch anal anastomosis (UC-IPAA) and who can be followed before and after disease development and serve as their own controls. Half of these patients will develop an inflammatory condition of their ileal pouch within two years (pouchitis). In an initial exploratory study of these patients, two discoveries were made which led to the following hypotheses: 1 IBD patients exhibit an anomalous transcriptional response to microbiota-derived signals that renders them susceptible to the development of pouchitis, but is not sufficient to cause disease. 2 Specific mucosal pathobionts that emerge through selection or acquisition of virulence factors trigger pouchitis on the patient's background of genetic susceptibility. With regard to the latter, differences in specific Bacteroides fragilis capsular polysaccharide (CPS) biosynthetic gene clusters among luminal and mucosal strains may transform a commensal microbe to a pathobiont. Three aims are proposed: (1) to investigate the stimuli, role, and functional impact of specific host genes of the anomalous UC pouch transcriptome that may promote disease susceptibility, by employing single-cell approaches to define cell-type and -specific contributions and mechanisms (2) to identify and isolate microbes involved in promoting pouchitis including CPS variants and determine the their functional impact on host epithelia and immune cells and role and contribution to initiation of disease, (3) to develop a research resource for the broader community to advance discovery-based or hypothesis-generating science. The study will be conducted by a multi-disciplinary team of experts with a proven and successful record of collaboration and synergy. The proposal links basic, translational, and clinical scientific research by focusing on molecular and genetic mechanisms of host and microbial cells with the objective of building a base for future interventions for many types of complex immune diseases ultimately, we will be able to alter the outcome for these patients.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult by deterministic_prior with confidence 0.90. Assay shotgun_dna.

  • host external_curation.infant_catalog · “infant triage reason_code age_adult_only”
  • body site study.title · “Human gut metagenome, whole genomic”
  • body site study.description · “total proctocolectomy with ileal pouch anal anastomosis”
  • life stage external_curation.infant_catalog · “infant triage reason_code age_adult_only”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN36823508countryUSR10.90sample.attr.geo_loc_nameUSA: Illinois, Chicago
SAMN36823508health_conditionulcerative_colitisR40.50study.descriptionmedically-refractory ulcerative colitis (UC)
SAMN36823508health_condition_detailUlcerative colitis patients with UC-IPAA surgeryR40.50study.descriptionmedically-refractory ulcerative colitis (UC)
SAMN36823508latitude41.7897R10.90biosample.attribute:lat_lon41.78966349 N 87.60359836 W
SAMN36823508location_localityChicagoR10.85biosample.attribute:geo_loc_nameUSA: Illinois, Chicago
SAMN36823508location_regionIllinoisR10.85biosample.attribute:geo_loc_nameUSA: Illinois, Chicago
SAMN36823508longitude-87.6036R10.90biosample.attribute:lat_lon41.78966349 N 87.60359836 W
SAMN36823508subject_id801R10.70sample.name_rule:biosample.aliasp801-00M-PO-BAG
SAMN36823509subject_id800R10.70sample.name_rule:aliasp800-00M-PO-LUM
Sequencing

108 runs over 108 samples · mean 10.50 Gbp per run (median 10.04 Gbp, total 1,133.68 Gbp; 108 runs with a base count) · layout PAIRED 108 · platform ILLUMINA 108 · models NextSeq 500 (108) · 85% of runs with a Sandpiper profile · first public 2023-08-19

Authors (0)

No author record.

Downloads

PRJNA1004651.csv.gz (3.4 KB) · parquet (73.8 KB) — all 108 samples, every field with route and confidence · PRJNA1004651_determinations.csv.gz (6.4 KB) — 864 evidence rows

Samples (108 · every field this project has values for · hover a cell for its source)
Loading the sample table…